Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.62M Sell
57,566
-3,927
-6% -$105K 0.19% 105
2025
Q4
$1.53M Sell
61,493
-1,375
-2% -$34.7K 0.18% 113
2025
Q3
$1.6M Sell
62,868
-20,712
-25% -$511K 0.19% 108
2025
Q2
$2.03M Sell
83,580
-6,168
-7% -$144K 0.27% 89
2025
Q1
$2.27M Buy
89,748
+11,796
+15% +$309K 0.3% 79
2024
Q4
$2.07M Sell
77,952
-28,164
-27% -$764K 0.27% 84
2024
Q3
$3.07M Sell
106,116
-18,157
-15% -$530K 0.39% 63
2024
Q2
$3.48M Sell
124,273
-37,752
-23% -$1.04M 0.46% 57
2024
Q1
$4.5M Buy
162,025
+5,308
+3% +$147K 0.59% 47
2023
Q4
$4.51M Buy
156,717
+638
+0.4% +$19.3K 0.59% 45
2023
Q3
$5.18M Sell
156,079
-8,874
-5% -$314K 0.73% 34
2023
Q2
$6.05M Sell
164,953
-2,289
-1% -$89.1K 0.8% 30
2023
Q1
$6.82M Buy
167,242
+5,509
+3% +$238K 0.92% 27
2022
Q4
$8.29M Buy
161,733
+3,845
+2% +$184K 1.15% 23
2022
Q3
$6.91M Buy
157,888
+1,270
+0.8% +$61.7K 1.05% 23
2022
Q2
$8.21M Buy
156,618
+2,536
+2% +$129K 1.18% 21
2022
Q1
$7.98M Sell
154,082
-1,616
-1% -$83.8K 0.98% 25
2021
Q4
$9.19M Sell
155,698
-12,620
-7% -$625K 1.06% 20
2021
Q3
$7.24M Sell
168,318
-5,354
-3% -$237K 0.88% 28
2021
Q2
$6.8M Sell
173,672
-2,035
-1% -$79.1K 0.8% 31
2021
Q1
$6.36M Buy
175,707
+93
+0.1% +$3.3K 0.8% 31
2020
Q4
$6.46M Sell
175,614
-7,235
-4% -$265K 0.88% 29
2020
Q3
$6.37M Buy
182,849
+861
+0.5% +$30.2K 0.96% 27
2020
Q2
$5.65M Buy
181,988
+13,764
+8% +$468K 0.95% 27
2020
Q1
$5.21M Buy
168,224
+2,529
+2% +$86.2K 1.12% 25
2019
Q4
$6.16M Buy
165,695
+9,781
+6% +$348K 1.08% 27
2019
Q3
$5.32M Buy
155,914
+1,119
+0.7% +$40.7K 1.01% 29
2019
Q2
$6.36M Buy
154,795
+2,672
+2% +$106K 1.22% 25
2019
Q1
$6.13M Sell
152,123
-909
-0.6% -$36.4K 1.24% 24
2018
Q4
$6.34M Buy
153,032
+9,280
+6% +$385K 1.41% 20
2018
Q3
$6.01M Sell
143,752
-1,774
-1% -$68.3K 1.18% 24
2018
Q2
$5.01M Sell
145,526
-1,688
-1% -$57.7K 0.94% 33
2018
Q1
$4.96M Sell
147,214
-18,861
-11% -$648K 0.93% 33
2017
Q4
$5.71M Buy
166,075
+16,309
+11% +$556K 0.61% 50
2017
Q3
$4.93M Buy
149,766
+645
+0.4% +$20.7K 0.54% 62
2017
Q2
$4.75M Buy
149,121
+20,997
+16% +$662K 0.51% 62
2017
Q1
$4.16M Buy
128,124
+12,866
+11% +$406K 0.87% 36
2016
Q4
$3.55M Buy
115,258
+1,486
+1% +$45.4K 0.78% 39
2016
Q3
$3.65M Buy
113,772
+1,696
+2% +$56.7K 0.83% 37
2016
Q2
$3.74M Buy
112,076
+1,168
+1% +$37.3K 0.88% 33
2016
Q1
$3.12M Sell
110,908
-160
-0.1% -$4.57K 0.75% 37
2015
Q4
$3.4M Buy
111,068
+8,582
+8% +$270K 0.82% 36
2015
Q3
$3.05M Hold
102,486
0.79% 37
2015
Q2
$3.26M Sell
102,486
-316
-0.3% -$10.3K 0.77% 39
2015
Q1
$3.39M Sell
102,802
-738
-0.7% -$23.5K 0.79% 36
2014
Q4
$3.06M Buy
+103,540
New +$2.97M 0.69% 39

Other funds holding PFE

Community Bank's PFE Position: Q1 2026 in Review

Community Bank reduced its Pfizer (PFE) stake by 6.4% in Q1 2026, selling an estimated $105K and leaving 57,566 shares worth $1.62M. The position accounts for 0.19% of the portfolio, ranked #105.

Community Bank first reported a position in PFE in Q4 2014 and has held it in 46 quarters since. The position peaked at $9.19M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Community Bank held 57,566 shares of Pfizer worth $1.62M as of Q1 2026.
  • Community Bank sold 3,927 Pfizer shares in Q1 2026, an estimated $105K.
  • Pfizer made up 0.19% of Community Bank's portfolio in Q1 2026, its #105 holding.
  • Community Bank first reported a position in Pfizer in Q4 2014 and has held it in 46 quarters since.
  • Community Bank's Pfizer position peaked at $9.19M in Q4 2021.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Community Bank's 13F filing for Q1 2026, filed 12 May 2026.